111 – 120 of 458
- show: 10
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2014
-
Mark
Targeted Prostate Cancer Screening in BRCA1 and BRCA2 Mutation Carriers: Results from the Initial Screening Round of the IMPACT Study.
2014) In European Urology(
- Contribution to journal › Article
-
Mark
Influence of blood prostate specific antigen levels at age 60 on benefits and harms of prostate cancer screening : Population based cohort study
(
- Contribution to journal › Article
-
Mark
It Ain't what you do, it's the way you do it : Five golden rules for transforming prostate-specific antigen screening
(
- Contribution to journal › Article
-
Mark
Aminopeptidase activities as prospective urinary biomarkers for bladder cancer
(
- Contribution to journal › Article
-
Mark
Analytic and clinical validation of a prostate cancer-enhanced messenger RNA detection assay in whole blood as a prognostic biomarker for survival
(
- Contribution to journal › Article
-
Mark
Evaluating the Prostate Cancer Prevention Trial High Grade prostate cancer risk calculator in 10 international biopsy cohorts : Results from the prostate biopsy collaborative group
(
- Contribution to journal › Article
-
Mark
Emerging PSA-based tests to improve screening
(
- Contribution to journal › Scientific review
-
Mark
Acoustophoresis for label-free separation and concentration of cancer cells
2014) 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 In 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 p.2508-2509(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
Improved acoustophoretic circulating tumor cell (CTC) separation for low target cell numbers in clinical volumes
2014) 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 In 18th International Conference on Miniaturized Systems for Chemistry and Life Sciences, MicroTAS 2014 p.594-596(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
The Added Value of Percentage of Free to Total Prostate-specific Antigen, PCA3, and a Kallikrein Panel to the ERSPC Risk Calculator for Prostate Cancer in Prescreened Men.
(
- Contribution to journal › Article